• Molecular NameTetrabenazine
  • SynonymTetra benazin; Tetrabenazina [inn-spanish]; Tetrabenazinum [inn-latin]; Tetrabenzaine; Tetrabenzine
  • Weight317.429
  • Drugbank_IDDB04844
  • ACS_NO58-46-8
  • Show 2D model
  • LogP (experiment)3.18
  • LogP (predicted, AB/LogP v2.0)3.07
  • pkaN/A
  • LogD (pH=7, predicted)2.77
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-3.23
  • LogSw (predicted, AB/LogsW2.0)0.31
  • Sw (mg/ml) (predicted, ACD/Labs)0.15
  • No.of HBond Donors0
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds4
  • TPSA38.77
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA drug for the symptomatical treatment of hyperkinetic movement disorder
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability5.0
  • Protein binding83.5
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic (CYP2D6-mediated)
  • Half lifeN/A
  • ExcretionRenal and fecal
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)LD50=500 (intraperitoneal)